Data as of May 17
| +0.96 / +2.08%|
AbbVie, Inc. is a research-based biopharmaceutical company which is engaged in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. Its products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease, and complications associated with chronic kidney disease, among other indications. The company also has a pipeline of new medicines, including various compounds or indications in Phase II or Phase III development across such medical specialties as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. AbbVie was founded on April 10, 2012 and is headquartered in North Chicago, IL.
|Richard A. Gonzalez||Chairman & Chief Executive Officer|
|Azita Saleki-Gerhardt, PhD||Senior Vice President-Operations|
|William J. Chase||Chief Financial Officer & Executive Vice President|
|John M. Leonard, MD||Chief Scientific Officer & Senior Vice President|
|Thomas A. Hurwich||Chief Accounting Officer, VP & Controller|